AGT and acute respiratory distress syndrome: In human trials, patients with ARDS of different etiologies treated with i.v. rhACE2 showed reduction in Ang II and increase in Ang1-7 levels, although rhACE2 failed to improve significantly the clinical indicators of ARDS but, at least, was well tolerated [75].